868sek
-0,2 %
Date:2024-12-20Time:17:29:00Latest report:Q3-2024List:First NorthTicker:CLBIO
Market Cap:213 msekEnterprise Value:205 msekNet Sales:14,0 msekEarnings:-9,63 msekEmployees:0ISIN:SE0006887451

Ratios

10-year key figure history for Corline Biomedical turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Corline Biomedical with index and moving average MA50 and MA200.

Stockprice:8,68
MA50:7,43
MA200:10,13
Price/MA200:-14,3 %
RSI (14):68,9
Price/MA50:16,8 %

Description

Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Pharmaceuticals